The Advisory Committee to the Director of the National Institutes of Health (NIH) will be hosting a meeting focused on a research report on helping to end the national opioid crisis. NIH has been intensely engaged for several months in planning stages with the Foundation for NIH (FNIH) and potential external partners to identify and outline options for collaboration to address the opioid crisis. Discussions have included dozens of companies, a few of which manufacture opioids and are the target of current litigation by several state Attorneys General and other entities. While there may be significant opportunity to advance addiction and treatment research with the financial, technical, and intellectual support of this substantial roster of private sector companies, one must consider the ethics of accepting contributions from those companies that are perceived as having contributed to the crisis. As a likely member of this potential partnership, FNIH is also contemplating these issues, which will be discussed in detail at an FNIH board meeting in March.
The report will be given by the Working Group on Ethical Considerations for Industry Partnership on Research to Help End the Opioid Crisis. The meeting will be held as a teleconference call only and is open to the public to dial-in for participation. Any interested person may also file written comments with the committee by forwarding the statement to the Contact Person listed on the notice.
More information is available via the Federal Register notice.